IDEAS home Printed from https://ideas.repec.org/h/ito/pchaps/239143.html
   My bibliography  Save this book chapter

CRISPR Cas/Exosome Based Diagnostics: Future of Early Cancer Detection

In: Rural Health

Author

Listed:
  • P.P. Mubthasima
  • Kaumudi Pande
  • Rajalakshmi Prakash
  • Anbarasu Kannan

Abstract

Trending and Thriving, CRISPR/Cas has expanded its wings towards diagnostics in recent years. The potential of evading off targeting has not only made CRISPR/Cas an effective therapeutic aid but also an impressive diagnostic tool for various pathological conditions. Exosomes, 30 - 150nm sized extracellular vesicle present and secreted by almost all type of cells in body per se used as an effective diagnostic tool in early cancer detection. Cancer being the leading cause of global morbidity and mortality can be effectively targeted if detected in the early stage, but most of the currently used diagnostic tool fails to do so as they can only detect the cancer in the later stage. This can be overcome by the use of combo of the two fore mentioned diagnostic aids, CRISPR/Cas alongside exosomes, which can bridge the gap compensating the cons. This chapter focus on two plausible use of CRISPR/Cas, one being the combinatorial aid of CRISPR/Cas and Exosome, the two substantial diagnostic tools for successfully combating cancer and other, the use of CRISPR in detecting and targeting cancer exosomes, since they are released in a significant quantity in early stage by the cancer cells.

Suggested Citation

  • P.P. Mubthasima & Kaumudi Pande & Rajalakshmi Prakash & Anbarasu Kannan, 2022. "CRISPR Cas/Exosome Based Diagnostics: Future of Early Cancer Detection," Chapters, in: Umar Bacha (ed.), Rural Health, IntechOpen.
    • Handle: RePEc:ito:pchaps:239143
    DOI: 10.5772/intechopen.99900
    as

    Download full text from publisher

    File URL: https://www.intechopen.com/chapters/78447
    Download Restriction: no
    File URL: https://libkey.io/10.5772/intechopen.99900?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    CRISPR/Cas; exosomes; cancer; Cas12a; Cas13a; exosomal noncoding RNAs;
    All these keywords.

    JEL classification:

    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ito:pchaps:239143. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Slobodan Momcilovic (email available below). General contact details of provider: http://www.intechopen.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.